Sai-Wen Tang

Company: Acepodia Biotech

Job title: Director - Research & Development

Seminars:

Antibody-Cell Conjugation Technology: Cutting-Edge Platform for Off-the-Shelf Cell Therapies 10:15 am

Advantages of ACC technology in developing allogeneic cell therapies Mechanism of action of antibody-conjugated gamma delta T cells against tumors Preclinical evidence of ACC products against hematologic and solid malignancies Updates for IND application of ACC productsRead more

day: Conference Day One

Panel Discussion: Reflecting on a Year of Industry Advances: Key Insights from 2023 & Anticipating the Path Ahead in 2024 9:00 am

Reviewing latest clinical updates and identifying key areas of growth in the past year Discussing the race to clinic and attracting investors to fund scale ups into the clinic Considering current gamma delta t therapies to drive solid tumor success What does 2024 look like for the field and where is it headed?Read more

day: Conference Day One